Incidence of Adverse Drug Events and Potential Adverse Drug Events: Implications for Prevention

JAMA: The Journal of the American Medical Association

Volumn 274, Issue 1, 1995, Pages 29-34

  Bates, David W ^a   Cullen, David J ^b   Laird, Nan ^c   Petersen, Laura A ^a   Small, Stephen D ^b   Servi, Deborah ^d   Laffel, Glenn ^e   Sweitzer, Bobbie J ^b   Shea, Brian F ^f   Hallisey, Robert ^f   Vander Vliet, Martha ^a   Nemeskal, Roberta ^b   Leape, Lucian L ^g  

^a Division of General Medicine   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d Health Policy and Management   (United States)

^e HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^f Department of Pharmacy ^*  (United States)

^g ADE Prevention Study Group Health Policy and Management ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG; MORPHINE SULFATE;

ADVERSE DRUG REACTION; ARTICLE; DISEASE CONTROL; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG HYPERSENSITIVITY; HUMAN; INTENSIVE CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELF REPORT;

BOSTON; DRUG THERAPY; HUMAN; IATROGENIC DISEASE; INTENSIVE CARE UNITS; MEDICATION ERRORS; MEDICATION SYSTEMS, HOSPITAL; PHARMACEUTICAL PREPARATIONS; PROSPECTIVE STUDIES; RISK MANAGEMENT; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0029066463     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.1995.03530010043033     Document Type: Article

References (41)

1. Brennan TA, Leape LL, Laird N, et al. Incidence of adverse events and negligence in hospitalized patients: results from the Harvard Medical Practice Study I. N Engl J Med. 1991;324:370-376.
2. Institute of Medicine. Injury in America. Washington, DC: National Academy Press; 1985.
3. Leape LL, Lawthers AG, Brennan TA, Johnson WG. Preventing medical injury. Qual Rev Bull. 1993;19:144-149.
4. Leape LL, Brennan TA, Laird N, et al. The nature of adverse events in hospitalized patients: results from the Harvard Medical Practice Study II. N Engl J Med. 1991;324:377-384.
5. Classen DC, Pestotnik SL, Evans RS, Burke JP. Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991;266:2847-2851.
6. Faich GA. National adverse drug reaction reporting, 1984-1989. Arch Intern Med. 1991;151:1645-1647.
7. Faich GA. Adverse-drug-reaction monitoring. N Engl J Med. 1986;314:1589-1592.
8. Melmon KL. Preventable drug reactions—causes and cures. Semin Med Beth Israel Hosp. 1971;284: 1361-1367.
9. Keith MR, Bellanger-McCleery RA, Fuchs JE Jr. Multidisciplinary program for detecting and evaluating adverse drug reactions. Am J Hosp Pharm. 1989;46:1809-1812.
10. Seidl LG, Thornton G, Smith JW, et al. Studies on the epidemiology of adverse drug reactions, III: reactions in patients on a general medical service. Bull Johns Hopkins Hosp. 1966;119:299-315.
11. Jick H. Adverse drug reactions: the magnitude of the problem. J Allergy Clin Immunol. 1984;74: 555-557.
12. Hoddinott BC, Gowdey CW, Coulter WK, et al. Drug reactions and errors in administration on a medical ward. Can Med Assoc J. 1967;97:1001-1006.
13. Ogilvie RI, Ruedy J. Adverse drug reactions during hospitalization. Can Med Assoc J. 1967;97: 1450-1457.
14. Hurwitz N, Wade OL. Intensive hospital monitoring of adverse reactions to drugs. BMJ. 1969;1: 531-536.
15. Berry LL, Segal R, Sherrin TP, Fudge KA. Sensitivity and specificity of three methods of detecting adverse drug reactions. Am J Hosp Pharm. 1988;45:1534-1539.
16. Karch FE, Lasagna L. Adverse drug reactions: a critical review. JAMA. 1975;234:1236-1241.
17. Forrester JW. Counterintuitive behavior of social systems. MIT Technol Rev. 1971;73:52-68.
18. Bates DW, Leape LL, Petrycki S. Incidence and preventability of adverse drug events in hospitalized adults. J Gen Intern Med. 1993;8:289-294.
19. Rind DM, Safran C, Phillips RS, et al. The effect of computer-based reminders on the management of hospitalized patients with worsening renal function. Proc Annu Symp Comput Appl Med Care. 1991;15:28-32.
20. Evans RS, Pestotnik SL, Classen DC, Horn SD, Bass SB, Burke JP. Preventing adverse drug events in hospitalized patients. Ann Pharmacother. 1994;28:523-527.
21. Berwick DM. Continuous improvement as an ideal in health care. N Engl J Med. 1989;320:53-56.
22. Evans RS, Classen DC, Stevens LE, et al. Using a hospital information system to assess the effects of adverse drug events. Proc Annu Symp Comput Appl Med Care. 1993;17:161-165.
23. National Association of Insurance Commissioners. Medical Malpractice Closed Claims, 1975-1978. Brookfield, Wis: National Association of Insurance Commissioners; 1980.
24. Leape LL, Bates DW, Cullen DJ, et al. Systems analysis of adverse drug events. JAMA. 1995;274: 35-43.
25. Dubois RW, Brook RH. Preventable deaths: who, how often, and why. Ann Intern Med. 1988; 190:582-589.
26. Folli HL, Poole RI, Benitz WE, Russo JC. Medication error prevention by clinical pharmacists in two children's hospitals. Pediatrics. 1987;79:718-722.
27. SAS. Release 6.03. Cary, NC: SAS Institute Inc; 1988.
28. StatXact User Manual, Version 2. Cambridge, Mass: CYTEL Software Corporation; 1991.
29. Wan TTH, Shukla RK. Contextual and organizational correlates of the quality in hospital nursing care. Qual Rev Bull. 1987;13:61-64.
30. O'Neil AC, Petersen LA, Cook EF, Bates DW, Lee TH, Brennan TA. Physician reporting compared with medical-record review to identify adverse medical events. Ann Intern Med. 1993;119: 370-376.
31. Kessler DA. Introducing MEDWatch: a new approach to reporting medication and device adverse effects and product problems. JAMA. 1993; 269:2765-2768.
32. Beers M, Avorn J, Soumerai SB, Everitt DE, Sherman DS, Salem S. Psychoactive medication use in intermediate-care facility residents. JAMA. 1988;260:3016-3020.
33. Lesar TS, Briceland LL, Delcoure K, Parmalee JC, Masta-Gornic V, Pohl H. Medication prescribing errors in a teaching hospital. JAMA. 1990;263: 2329-2334.
34. Gosney M, Tallis R. Prescription of contraindicated and interacting drugs in elderly patients admitted to hospital. Lancet. 1984;2:564-567.
35. Bates DW, Kuperman G, Teich JM. Computerized physician order entry and quality of care. Qual Manage Health Care. 1994;2(4):18-27.
36. Bates DW, O'Neil AC, Boyle D, et al. Potential identifiability and preventability of adverse events using information systems. J Am Med Informatics Assoc. 1994;1:404-411.
37. Laffel G, Blumenthal D. The case for using industrial quality management science in health care organizations. JAMA. 1989;262:2869-2873.
38. Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape LL. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10:199-205.
39. Koch KE. Use of standardized screening procedures to identify adverse drug reactions. Am J Hosp Pharm. 1990;47:1314-1320.
40. Grasela TH, Walawander CA, Kennedy DL, Jolson HM. Capability of hospital computer systems in performing drug-use evaluations and adverse drug event monitoring. Am J Hosp Pharm. 1993;50:1889-1895.
41. Fuchsberg A. Medical malpractice—catch 29 or catch 22. Trial Lawyers Q. 1978;12:9-15.